Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer
Evgenii N. Tcyganov, … , Yulia Nefedova, Dmitry I. Gabrilovich
Evgenii N. Tcyganov, … , Yulia Nefedova, Dmitry I. Gabrilovich
Published July 6, 2021
Citation Information: J Clin Invest. 2021;131(16):e145971. https://doi.org/10.1172/JCI145971.
View: Text | PDF
Research Article Immunology Oncology Article has an altmetric score of 1

Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer

  • Text
  • PDF
Abstract

Myeloid-derived suppressor cells (MDSCs) are major negative regulators of immune responses in cancer and chronic infections. It remains unclear if regulation of MDSC activity in different conditions is controlled by similar mechanisms. We compared MDSCs in mice with cancer and lymphocytic choriomeningitis virus (LCMV) infection. Chronic LCMV infection caused the development of monocytic MDSCs (M-MDSCs) but did not induce polymorphonuclear MDSCs (PMN-MDSCs). In contrast, both MDSC populations were present in cancer models. An acquisition of immune-suppressive activity by PMN-MDSCs in cancer was controlled by IRE1α and ATF6 pathways of the endoplasmic reticulum (ER) stress response. Abrogation of PMN-MDSC activity by blockade of the ER stress response resulted in an increase in tumor-specific immune response and reduced tumor progression. In contrast, the ER stress response was dispensable for suppressive activity of M-MDSCs in cancer and LCMV infection. Acquisition of immune-suppressive activity by M-MDSCs in spleens was mediated by IFN-γ signaling. However, it was dispensable for suppressive activity of M-MDSCs in tumor tissues. Suppressive activity of M-MDSCs in tumors was retained due to the effect of IL-6 present at high concentrations in the tumor site. These results demonstrate disease- and population-specific mechanisms of MDSC accumulation and the need for targeting different pathways to achieve inactivation of these cells.

Authors

Evgenii N. Tcyganov, Shino Hanabuchi, Ayumi Hashimoto, David Campbell, Gozde Kar, Timothy W.F. Slidel, Corinne Cayatte, Aimee Landry, Fernanda Pilataxi, Susana Hayes, Brian Dougherty, Kristin C. Hicks, Kathy Mulgrew, Chih-Hang Anthony Tang, Chih-Chi Andrew Hu, Wei Guo, Sergei Grivennikov, Mohammed-Alkhatim A. Ali, Jean-Christophe Beltra, E. John Wherry, Yulia Nefedova, Dmitry I. Gabrilovich

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 3 13 13 12 3 44
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (44)

Title and authors Publication Year
Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma
Chivite\u2010Lacaba M, Justo I, Utrero\u2010Rico A, Caso O, González\u2010Cuadrado C, Del Rey MJ, Laguna\u2010Goya R, Arroyo\u2010Ródenas J, Alfocea\u2010Molina Á, Ruigómez\u2010Martín CC, Serrano M, Pascual\u2010Palacios L, Mancebo ME, Paz\u2010Artal E
International Journal of Cancer 2025
MiR- 150 deletion promotes lung tumor growth by upregulating P-STAT3 and ROS in MDSCs
Qin A, Chen H, Xu F, Li W, Guo S, Zhang G, Zhang A, Zheng A, Tian F, Zheng Q
Scientific Reports 2025
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
Eruslanov E, Nefedova Y, Gabrilovich DI
Nature immunology 2025
Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy.
He J, Zhou Y, Sun L
Cell communication and signaling : CCS 2024
Parasite-induced IFN-γ regulates host defense via CD115 and mTOR-dependent mechanism of tissue-resident macrophage death
Martin AT, Giri S, Safronova A, Eliseeva SI, Kwok SF, Yarovinsky F
PLoS pathogens 2024
Endoplasmic Reticulum Stress in Hypertension and Salt Sensitivity of Blood Pressure.
Balhara M, Neikirk K, Marshall A, Hinton A Jr, Kirabo A
Current Hypertension Reports 2024
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y
Journal of Hematology & Oncology 2024
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.
De Leo A, Ugolini A, Yu X, Scirocchi F, Scocozza D, Peixoto B, Pace A, D'Angelo L, Liu JKC, Etame AB, Rughetti A, Nuti M, Santoro A, Vogelbaum MA, Conejo-Garcia JR, Rodriguez PC, Veglia F
Immunity 2024
PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma
Liu X, Liu M, Wu H, Tang W, Yang W, Chan TT, Zhang L, Chen S, Xiong Z, Liang J, Wai-Yiu Si-Tou W, Shu T, Li J, Cao J, Zhong C, Sun H, Kwong TT, Leung HH, Wong J, Bo-San Lai P, To KF, Xiang T, Jao-Yiu Sung J, Chan SL, Zhou J, Sze-Lok Cheng A
2024
Glioma-derived M-CSF and IL-34 license M-MDSCs to suppress CD8+ T cells in a NOS-dependent manner
Takacs GP, Garcia JS, Hodges CA, Kreiger CJ, Sherman A, Harrison JK
2024
Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin
Vlahopoulos SA
International Journal of Molecular Sciences 2024
CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8+ T Cells in a NOS-Dependent Manner
Takacs GP, Garcia JS, Hodges CA, Kreiger CJ, Sherman A, Harrison JK
Cancers 2024
Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment
Deng Y, Shi M, Yi L, Naveed Khan M, Xia Z, Li X
Heliyon 2024
Homeostasis control in health and disease by the unfolded protein response.
Acosta-Alvear D, Harnoss JM, Walter P, Ashkenazi A
Nature reviews. Molecular cell biology 2024
Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer.
Wan S, Li KP, Wang CY, Yang JW, Chen SY, Wang HB, Li XR, Yang L
Current cancer drug targets 2024
Identification of a distinctive immunogenomic gene signature in stage-matched colorectal cancer
Ahluwalia P, Mondal AK, Vashisht A, Singh H, Alptekin A, Ballur K, Omar N, Ahluwalia M, Jones K, Barrett A, Kota V, Kolhe R
Journal of Cancer Research and Clinical Oncology 2024
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Lou X, Gao D, Yang L, Wang Y, Hou Y
Journal of Translational Medicine 2023
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Hopkins FR, Govender M, Svanberg C, Nordgren J, Waller H, Nilsdotter-Augustinsson Å, Henningsson AJ, Hagbom M, Sjöwall J, Nyström S, Larsson M
Frontiers in immunology 2023
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner
Takacs GP, Kreiger CJ, Luo D, Tian G, Garcia JS, Deleyrolle LP, Mitchell DA, Harrison JK
Frontiers in immunology 2023
Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
Yao S, Yu Y, Xu L, Pan X
Frontiers in Oncology 2023
Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
Andrés CM, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E
Human vaccines 2023
Functional states of myeloid cells in cancer
van Vlerken-Ysla L, Tyurina YY, Kagan VE, Gabrilovich DI
Cancer Cell 2023
Therapeutic targeting of tumour myeloid cells.
Barry ST, Gabrilovich DI, Sansom OJ, Campbell AD, Morton JP
Nature reviews. Cancer 2023
Cancer immunity and immunotherapy beyond COVID-19
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP
Cancer Immunology, Immunotherapy 2023
The role of myeloid-derived suppressor cells in liver cancer
Zhou S, Zhao Z, Zhong H, Ren Z, Li Y, Wang H, Qiu Y
Discover. Oncology 2023
Control of immune cell function by the unfolded protein response.
Di Conza G, Ho PC, Cubillos-Ruiz JR, Huang SC
Nature reviews. Immunology 2023
How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System
Raines LN, Huang SC
ImmunoHorizons 2023
Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions.
Chaib M, Tanveer UA, Makowski L
Pharmacology & Therapeutics 2023
The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis.
Len JS, Koh CWT, Chan KR
Viruses 2023
Activating transcription factor 3 functionally reprograms the bone marrow niche to sustain breast cancer
Milena Perrone, Claudia Chiodoni, Mara Lecchi, Laura Botti, Matteo Milani, Daniele Lecis, Elda Tagliabue, Paolo Verderio, Sabina Sangaletti, Mario Colombo
Cancer research 2022
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
Sean Colligan, Robert A Zollo, Jennifer Peresie, Elliot D Kramer, Joseph Barbi, Prashant K Singh, Jianmin Wang, Mateusz Opyrchal, David Sykes, Michael Nemeth, Scott I. Abrams
Journal of Clinical Investigation 2022
Myeloid-Derived Suppressor Cells in Solid Tumors
T Ma, B Renz, M Ilmer, D Koch, Y Yang, J Werner, A Bazhin
Cells 2022
New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19
S Park, D Nam, H Seong, Y Hahn
Frontiers in immunology 2022
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases.
Faccani C, Rotta G, Clemente F, Fedeli M, Abbati D, Manfredi F, Potenza A, Anselmo A, Pedica F, Fiorentini G, Villa C, Protti MP, Doglioni C, Aldrighetti L, Bonini C, Casorati G, Dellabona P, de Lalla C
Life science alliance 2022
Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
Bottomley MJ, Harden PN, Wood KJ, Hester J, Issa F
Frontiers in immunology 2022
Immunotherapy of targeting MDSCs in tumor microenvironment
Sui H, Dongye S, Liu X, Xu X, Wang L, Jin CQ, Yao M, Gong Z, Jiang D, Zhang K, Liu Y, Liu H, Jiang G, Su Y
Frontiers in immunology 2022
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Liu Z, Zhou Z, Dang Q, Xu H, Lv J, Li H, Han X
Theranostics 2022
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer
Monteran L, Ershaid N, Doron H, Zait Y, Scharff Y, Ben-Yosef S, Avivi C, Barshack I, Sonnenblick A, Erez N
Nature Communications 2022
Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations
Martin C, Dhôte T, Ladjemi MZ, Andrieu M, Many S, Karunanithy V, Pène F, Da Silva J, Burgel PR, Witko-Sarsat V
Frontiers in immunology 2022
Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity.
Salvagno C, Mandula JK, Rodriguez PC, Cubillos-Ruiz JR
Trends in Cancer 2022
TLR7 controls myeloid-derived suppressor cells expansion and function in the lung of C57BL6 mice infected with Schistosoma japonicum.
Zhou L, Zhu Y, Mo L, Wang M, Lin J, Zhao Y, Feng Y, Xie A, Wei H, Qiu H, Huang J, Yang Q
PLoS neglected tropical diseases 2022
Endoplasmic Reticulum Quality Control in Immune Cells
Y Jiang, Z Tao, H Chen, S Xia
Frontiers in Cell and Developmental Biology 2021
IFN-γ mediates Paneth cell death via suppression of mTOR
A Araujo, A Safronova, E Burger, A López-Yglesias, S Giri, ET Camanzo, AT Martin, S Grivennikov, F Yarovinsky
eLife 2021
Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity
GD Conza, CH Tsai, H Gallart-Ayala, YR Yu, F Franco, L Zaffalon, X Xie, X Li, Z Xiao, LN Raines, M Falquet, A Jalil, JW Locasale, P Percipalle, D Masson, SC Huang, F Martinon, J Ivanisevic, PC Ho
Nature Immunology 2021

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
44 readers on Mendeley
See more details